 |
|
 |
- December 1, 2008 |
|
|
Welcome to the #1 online source of information for Diabetes Specialists! An international online community of more than 10,000 Diabetes Specialists.
CME on Diabetes is a website built to transmit top-level CME conferences given by international experts in endocrinology, insulin resistance, prediabetes, metabolic syndrome and type 2 diabetes. More than 2.6 million slides have been viewed since the website launch. Thank you for your continued support and commitment!
|
|
|
| Presentation |
|
"Prevention of Diabetes and Cardiovascular Disease"Dr. Lawrence A. Leiter (biography)
English - 2003-10-31 - 26 minutes
|
 | (56 slides) |
Summary :
The new 2003 CDA Guidelines show a stronger focus on treating cardiovascular disease, reflecting its important role in the mortality of diabetic patients. Lifestyle intervention should be used to reduce hypertension, failing which, there are a number of antihypertensive agents that have been recommended for use in monotherapy, and if necessary in combination, to achieve target BP levels. It was shown that patients with diabetes or renal impairment need 3.2 antihypertensive drugs on average to achieve BP targets (1).
Along with the new Guidelines there is emerging evidence suggesting that the control of postprandial hyperglycemia reduces risk of cardiovascular disease and hypertension in IGT patients (2), with new data coming out from a retrospective meta-analysis of studies on type 2 diabetic patients.
Copyright © 2003 E-MedHosting.com Inc
Learning objectives :
The participant will learn how the new CDA Clincal Practice Guidelines 2003 have changed to highlight the prevention of cardiovascular disease, and new information on postprandial hyperglycemia and cardiovascular risk.
Bibliographic references :
1. Bakris GL, Williams M, Dworkin L, Elliott WJ, Epstein M, Toto R, Tuttle K, Douglas J, Hsueh W, Sowers J. Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. «» Am J Kidney Dis. 2000 Sep;36(3):646-61.
2.Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M; STOP-NIDDM Trial Research Group. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial.«» JAMA. 2003 Jul 23;290(4):486-94.
|
|
|
|
|
|
| Search our website |
 |
| |
Would you like to know more about insulin resistance? Are you looking for information pertaining to Type 2 Diabetes? You can find what you are looking for in over 2000 references available on CMEonDiabetes. |
| |
|
|
| Social |
|
| |
Let others know about this presentation.
|
|
|
|
